Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.

Guervil, David J; Rosenberg, Amy F; Winterstein, Almut G; Harris, Neil S; Johns, Thomas E; Zumberg, Marc S

Guervil, David J; Rosenberg, Amy F; Winterstein, Almut G; Harris, Neil S; Johns, Thomas E; Zumberg, Marc S.

Affiliation

Guervil DJ; Department of Pharmacy, Shands Hospital, University of Florida, Gainesville, FL, USA. guervd@shands.ufl.edu

Ann Pharmacother ; 45(7-8): 861-8, 2011 Jul.

Article in En | MEDLINE | ID: mdl-21712506

Subject(s)

Anticoagulants/therapeutic use; Drug Monitoring/methods; Heparin/therapeutic use; Academic Medical Centers; Adult; Aged; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Antithrombin III/analysis; Blood Coagulation Tests; Cohort Studies; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Heparin/administration & dosage; Heparin/adverse effects; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Drug Monitoring / Anticoagulants Type of study: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google